StonvexLoading…
StonvexStonvexStonvexCore line items from FHB's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $880.79M | $808.54M | $836.94M | $793.07M |
Operating Income | $354.24M | $292.60M | $309.17M | $351.21M |
Net Income | $276.27M | $230.13M | $234.98M | $265.69M |
EPS (Diluted) | $2.20 | $1.79 | $1.84 | $2.08 |
Total Assets | $23.96B | $23.83B | $24.93B | $24.58B |
Total Liabilities | $21.19B | $21.21B | $22.44B | $22.31B |
Cash & Equivalents | $1.48B | $1.17B | $1.74B | $526.62M |
Free Cash Flow OCF − CapEx | $303.29M | $288.74M | $239.04M | $417.32M |
Shares Outstanding | 122.69M | 126.42M | 127.62M | 127.36M |